Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives ; volume:38 ; number:7 ; day:3 ; month:6 ; year:2024 ; pages:507-532 ; date:7.2024
CNS drugs ; 38, Heft 7 (3.6.2024), 507-532, 7.2024

Creator: Gucký, Adrián
Hamuľaková, Slávka

Contributor: SpringerLink (Online service)

DOI: 10.1007/s40263-024-01093-0

URN: urn:nbn:de:101:1-2408271258306.007135271893

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gucký, Adrián
Hamuľaková, Slávka
SpringerLink (Online service)

Other Objects (12)

Asymmetric organocatalyzed synthesis of coumarin derivatives

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Alzheimer’s Disease

Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease

Spectral properties of coumarin derivatives in various environments

Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

Alzheimer

Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease

Coumarin sulfonamide derivatives: An emerging class of therapeutic agents

Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling

Asymmetric organocatalyzed synthesis of coumarin derivatives

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Alzheimer’s Disease

Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease

Spectral properties of coumarin derivatives in various environments

Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

Alzheimer

Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease

Coumarin sulfonamide derivatives: An emerging class of therapeutic agents

Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling

Asymmetric organocatalyzed synthesis of coumarin derivatives

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Alzheimer’s Disease

Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease

Spectral properties of coumarin derivatives in various environments

Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

Alzheimer

Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease

Coumarin sulfonamide derivatives: An emerging class of therapeutic agents

Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Asymmetric organocatalyzed synthesis of coumarin derivatives

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Alzheimer’s Disease

Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease

Spectral properties of coumarin derivatives in various environments

Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

Alzheimer

Alzheimer

Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease

Coumarin sulfonamide derivatives: An emerging class of therapeutic agents

Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling

Asymmetric organocatalyzed synthesis of coumarin derivatives

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Alzheimer’s Disease

Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease

Spectral properties of coumarin derivatives in various environments

Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

Alzheimer

Alzheimer

Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease

Coumarin sulfonamide derivatives: An emerging class of therapeutic agents

Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling

Asymmetric organocatalyzed synthesis of coumarin derivatives

Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Alzheimer’s Disease

Beyond genetics: including the environmental dimension in amyloidosis mouse models for Alzheimer’s disease

Spectral properties of coumarin derivatives in various environments

Synthesis and Vasorelaxant Activity of Nitrate−Coumarin Derivatives

Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

Alzheimer

Alzheimer

Design, synthesis and biological evaluation of substituted pyrazoles endowed with brominated 4-methyl 7-hydroxy coumarin as new scaffolds against Alzheimer’s disease

Coumarin sulfonamide derivatives: An emerging class of therapeutic agents

Membrane‐Permeant, Bioactivatable Coumarin Derivatives for In‐Cell Labelling

Related objects

Reset password